Manchester Capital Management LLC Grows Stock Holdings in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Manchester Capital Management LLC grew its holdings in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 200.0% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 3,000 shares of the company’s stock after acquiring an additional 2,000 shares during the period. Manchester Capital Management LLC’s holdings in iShares U.S. Pharmaceuticals ETF were worth $204,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in the business. Global Retirement Partners LLC boosted its stake in shares of iShares U.S. Pharmaceuticals ETF by 454.1% during the 1st quarter. Global Retirement Partners LLC now owns 410 shares of the company’s stock worth $28,000 after purchasing an additional 336 shares during the period. National Bank of Canada FI raised its stake in shares of iShares U.S. Pharmaceuticals ETF by 274.0% during the fourth quarter. National Bank of Canada FI now owns 187 shares of the company’s stock valued at $35,000 after acquiring an additional 137 shares in the last quarter. Concourse Financial Group Securities Inc. boosted its holdings in shares of iShares U.S. Pharmaceuticals ETF by 331.0% in the first quarter. Concourse Financial Group Securities Inc. now owns 543 shares of the company’s stock valued at $37,000 after purchasing an additional 417 shares during the period. Geneos Wealth Management Inc. grew its stake in iShares U.S. Pharmaceuticals ETF by 274.6% in the first quarter. Geneos Wealth Management Inc. now owns 798 shares of the company’s stock worth $54,000 after purchasing an additional 585 shares in the last quarter. Finally, Valley Wealth Managers Inc. increased its holdings in iShares U.S. Pharmaceuticals ETF by 200.0% during the 1st quarter. Valley Wealth Managers Inc. now owns 900 shares of the company’s stock worth $61,000 after purchasing an additional 600 shares during the period.

iShares U.S. Pharmaceuticals ETF Stock Up 0.7 %

Shares of IHE stock traded up $0.45 on Friday, hitting $68.74. The stock had a trading volume of 88,685 shares, compared to its average volume of 72,243. iShares U.S. Pharmaceuticals ETF has a one year low of $55.36 and a one year high of $69.56. The business has a 50 day moving average price of $66.18 and a 200 day moving average price of $65.70. The company has a market cap of $694.27 million, a PE ratio of 6.49 and a beta of 0.58.

iShares U.S. Pharmaceuticals ETF Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.